SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Comi, G.
Right arrow Articles by Leocani, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Comi, G.
Right arrow Articles by Leocani, L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies

G. Comi

Department of Neurology, University of Milan, Scientific Institute H. San Raffaele, Milan, 20132 Italy

R. Nemni

Department of Neurology, University of Milan, Scientific Institute H. San Raffaele, Milan, 20132 Italy

S. Amadio

Department of Neurology, University of Milan, Scientific Institute H. San Raffaele, Milan, 20132 Italy

G. Galardi

Department of Neurology, University of Milan, Scientific Institute H. San Raffaele, Milan, 20132 Italy

L. Leocani

Department of Neurology, University of Milan, Scientific Institute H. San Raffaele, Milan, 20132 Italy

This review deals with the use of intravenous IVIg immunoglobulines in the treatment of chronic immune-mediated neuropathies: multifocal motor neuropathy, chronic inflammatory demyelinating polyneuropathy, neuropathies associated with monoclonal gammopathies. A particular attention is given to case series and trials which compare IVIg to other therapies, such as steroid treatment, immunosuppressors and plasma exchange. At present, clinical and instrumental data seem to indicate the short term efficacy of IVIg in multifocal motor neuropathies, especially as early treatment; further studies are need in order to prove its long term efficacy in this disease. Concerning chronic inflammatory demyelinating polyneuropathies, short term IVIg efficacy is comparable to that of plasma exchange and in the long term most patients need repeated treatments. Most patients respond to the initial therapy and the initial nonresponders usually improve with a second treatment modality.

Key Words: multifocal motor neuropathy • chronic inflammatory demyelinating polyradiculoneuropathy • intravenous gamma globulin • monoclonal gammopathy • steroid treatment • plasma exchange • treatment • immunoglobulin

Multiple Sclerosis, Vol. 3, No. 2, 93-97 (1997)
DOI: 10.1177/135245859700300207
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
M. D. Kazatchkine and S. V. Kaveri
Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
N. Engl. J. Med., September 6, 2001; 345(10): 747 - 755.
[Full Text] [PDF]


Advertisement